GH
TCRR

GAM Holding’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

GAM Holding’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-58,343
Closed -$957K – 356
2021
Q2 		$957K Hold
58,343
– – 0.04% 229
2021
Q1 		$1.29M Buy
+58,343
New +$1.59M 0.06% 224
2020
Q4 		– Sell
-166,600
Closed -$3.38M – 349
2020
Q3 		$3.38M Buy
166,600
+144,600
+657% +$2.54M 0.2% 156
2020
Q2 		$338K Buy
+22,000
New +$254K 0.02% 300

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

GAM Holding's TCRR Position: Q3 2021 in Review

GAM Holding sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q3 2021, closing a stake of 58,343 shares — an estimated $957K sold.

GAM Holding first reported a position in TCRR in Q2 2020 and held it in 4 quarters. The position peaked at $3.38M in Q3 2020. 117 funds tracked by Wall St. Rank hold TCRR as of Q3 2021.

  • GAM Holding reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • GAM Holding sold 58,343 TCR2 Therapeutics Inc. Common Stock shares in Q3 2021, an estimated $957K.
  • GAM Holding first reported a position in TCR2 Therapeutics Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • GAM Holding's TCR2 Therapeutics Inc. Common Stock position peaked at $3.38M in Q3 2020.
  • 117 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q3 2021.

Based on GAM Holding's 13F filing for Q3 2021, filed 12 Nov 2021.